Violation Tracker Individual Record
Company:Reckitt Benckiser Group plc
Date:July 11, 2019
Primary Offense:price-fixing or anti-competitive practices
Reckitt Benckiser Group agreed to pay $50 million to settle allegations that it violated the antitrust laws through a deceptive scheme to thwart lower-priced generic competition to its branded drug Suboxone.
Level of Government:federal
Action Type:agency action
Agency:Federal Trade Commission
Civil or Criminal Case:civil
HQ Country of Parent:Britain
Ownership Structure of Parent:publicly traded
Major Industry of Parent:household and personal care products
Specific Industry of Parent:personal care products
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.